Keyword: GlaxoSmithKline (GSK)
News
18.08.2014
- Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief...
News
12.08.2014
- Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries headquartered in Redwood City, Calif./USA, has signed a platform technology license...
Markets & Companies
29.07.2014
- Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...
News
28.07.2014
- Allegations of corruption continue to dog British pharmaceutical company GlaxoSmithKline (GSK). The latest reports come from Syria, where the drugmaker and its distributor have...
News
16.07.2014
- Prosecutors in Shanghai have indicted Peter Humphrey, a 58-year-old UK citizen, and Yu Yingzeng, a 61-year-old US citizen, for illegally obtaining personal information on Chinese...
News
02.07.2014
- GlaxoSmithKline (GSK) has confirmed the existence of an intimate video recording of its former China head, Mark Reilly, which the London-based Sunday Times reported kicked off a...
News
05.06.2014
- Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...
News
01.06.2014
- UK pharmaceutical producer GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs, news agencies report, citing people familiar...
